DMARDs & Immunosuppressives

Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis

June 18, 2018 • By Michele B. Kaufman, PharmD, BCGP

Targeted Rheumatoid Arthritis Treatment Does Not Improve Mental Health

June 14, 2018 • By Will Boggs MD

AbbVie’s RA Drug Succeeds in Late Stage Study

June 11, 2018

Prenatal TNF Inhibitor Exposure Not Linked to Serious Infections

May 29, 2018 • By Anne Harding

Report Shows Rituximab May Help Treat MCTD-Associated PAH

April 26, 2018 • By Josna Haritha, MD, MPH, Huzaefah Syed, MD, Abhishek Nandan, MD, & Daniel Grinnan, MD

Can Certain DMARDs Treat Dementia?

April 26, 2018 • By Larry Beresford

DMARDs & Biologics Info for Rheumatology Nurses

March 17, 2018 • By Larry Beresford

Ixekizumab Promising for AS; Plus Certolizumab Pegol Studied for Psoriasis

March 14, 2018 • By Michele B. Kaufman, PharmD, BCGP

EU Approves Marketing for Ixekizumab in Adults with PsA

February 7, 2018 • By Michele B. Kaufman, PharmD, BCGP

Upadacitinib Receives Breakthrough Designation, Abatacept Use Expands in Australia & More

January 31, 2018 • By Michele B. Kaufman, PharmD, BCGP

1
2
3
…
13
Next Page »